Ambee Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	183.57	230.55	219.3	198.1	180.99	98.98
Revenue Growth (YoY)	-18.88%	5.13%	10.71%	9.45%	82.86%	-65.31%
Cost of Revenue	98.33	119.16	103.14	92.53	83.62	58.27
Gross Profit	85.24	111.39	116.16	105.56	97.37	40.71
Selling, General & Admin	79.99	104	103.75	92.39	82.51	47.99
Operating Expenses	79.99	104	103.75	92.39	82.51	47.99
Operating Income	5.25	7.39	12.41	13.17	14.86	-7.28
Interest Expense	-0.05	-0.09	-0.58	-2.49	-4.62	-5
Interest & Investment Income	3.6	-	-	-	-	-
Other Non Operating Income (Expenses)	-	-	0	-0	-	0
EBT Excluding Unusual Items	8.8	7.3	11.83	10.68	10.23	-12.28
Pretax Income	8.8	7.3	11.83	10.68	10.23	-12.28
Income Tax Expense	2.2	1.99	2.15	1.59	2.18	0.73
Net Income	6.6	5.31	9.68	9.09	8.06	-13.01
Net Income to Common	6.6	5.31	9.68	9.09	8.06	-13.01
Net Income Growth	-33.63%	-45.17%	6.53%	12.79%	-	-
Shares Outstanding (Basic)	2	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2	2
EPS (Basic)	2.75	2.21	4.03	3.79	3.36	-5.42
EPS (Diluted)	2.75	2.21	4.03	3.79	3.36	-5.42
EPS Growth	-33.63%	-45.17%	6.53%	12.79%	-	-
Free Cash Flow	5.25	-2.06	-68.12	-35.34	-74.71	-5.45
Free Cash Flow Per Share	2.19	-0.86	-28.39	-14.72	-31.13	-2.27
Dividend Per Share	1.000	1.000	1.000	1.500	1.000	-
Dividend Growth	-	-	-33.33%	50.00%	-	-
Gross Margin	46.43%	48.31%	52.97%	53.29%	53.80%	41.13%
Operating Margin	2.86%	3.21%	5.66%	6.65%	8.21%	-7.36%
Profit Margin	3.60%	2.30%	4.42%	4.59%	4.45%	-13.14%
Free Cash Flow Margin	2.86%	-0.89%	-31.06%	-17.84%	-41.28%	-5.51%
EBITDA	12.27	12.46	18.26	20.16	19.64	-1.67
EBITDA Margin	6.69%	5.40%	8.32%	10.18%	10.85%	-1.69%
D&A For EBITDA	7.02	5.07	5.84	6.99	4.79	5.61
EBIT	5.25	7.39	12.41	13.17	14.86	-7.28
EBIT Margin	2.86%	3.20%	5.66%	6.65%	8.21%	-7.36%
Effective Tax Rate	24.96%	27.26%	18.16%	14.90%	21.25%	-
Advertising Expenses	-	0.82	1.12	1.43	4.58	0.93

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.